Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 22, 2000
Association of an ERCC1 polymorphism with adult-onset gliomaP Chen, J Wiencke, K Aldape, et al.Cell Death & Disease|March 4, 2011
Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenograftsY Liu, F Lang, X Xie, et al.Cancer|May 23, 2000
Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma StudyK Aldape, M L Simmons, R L Davis, et al.Journal of Neuropathology and Experimental Neurology|November 15, 2001
Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?P C Burger, D K Pearl, K Aldape, et al.Cancer Research|May 19, 2001
Ethnicity delineates different genetic pathways in malignant gliomaP Chen, K Aldape, J K Wiencke, et al.Journal of Cell Science|June 1, 1995
Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodelingJ M Breuss, J Gallo, H M DeLisser, et al.Cancer Research|February 28, 2001
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patientsM L Simmons, K R Lamborn, M Takahashi, et al.Glia|December 18, 2001
Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activationJ M Soos, J I Krieger, O Stüve, et al.British Journal of Cancer|October 15, 2014
Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumoursR R Singh, K P Patel, M J Routbort, et al.Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.Pageof 3